22-05-2025
Conference MDAngle: ASCO 2025 Early Breast Cancer
Preconference Considerations
ASCO 2025: Previewing Updates in Early-Stage Breast Cancer
Dr Chavez MacGregor eagerly awaits the 2025 ASCO Annual Meeting, especially the sessions on early-stage breast cancer. She highlights new data on treatment optimization for HER2-positive disease and updates on managing HR-positive breast cancer in premenopausal women, including results from key trials like SOFT, TEXT, and ASTRRA. Dr Chavez MacGregor is also looking forward to sessions on circulating tumor DNA and emerging therapies for improving quality of life during endocrine treatment. Quick Clinical Takeaways
Coming soon: Dr Chavez MacGregor will share new data and insights on early breast cancer directly after ASCO. How Will My Patients Benefit?
Coming soon: Reflections from Dr Chavez MacGregor on how new data from ASCO will affect her patients with early breast cancer. Lead image: Medscape
